LGND trade ideas
Stocks To Watch This WeekThe Bull Market is strong, the end of 2020 saw many growth names pull in or consolidate which gives a better reward to risk entry. Some of these charts still need to confirm their price action. This video is my watchlist. Most of these names are at or near all time highs or multi year highs. There are 30 total stocks on this list. I add an additional 3 stocks that are on my potential short squeeze watch list. Many of these have IPO'd in the last few years and still have a growth story ahead of them. Know your time frame and risk tolerance, grab a pencil and paper and jot down the names that look interesting to you and then make the trade your own. Good Luck!
LGND. Consolidation and preparing for grow up.#LGND. The share has been in consolidation for a month now in the range of 108-118. EMA50 is preparing to pass EMA100 from bottom to top on the daily chart, which will be a strong enough signal to buy. If out of the range, the growth can be explosive, as Short Float is 58.36% Possible TP levels are shown on the chart.
LGND all not lost?Right at a support from horizontal and rising trendline. RSI and MACD are way oversold and is at place where it bounced last time at these levels.200dma support right underneath. Some bounce here should be certainly in. If not then it would provide a good short opportunity with a stop just above 111.
Ligand Pharmaceuticals best choise in the Biopharma IndustryFundamentals :
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing and acquiring technologies that help pharmaceutical companies discover and develop medicines worldwide. Ligand Pharmaceuticals has a compelling business model that offers higher than average return with lower than average risk.
Ligand's P/E of 8 is cheap as I mentioned. Forward P/E is indeed higher compared to the industry but I think it is still in range. Even if it is expensive, I think it is justified given the high return to equity that Ligand has generated in 2015. And as a growth stock, Ligand's growth comes at a cheaper price compared to the industry as represented by PE/G. So, do I think Ligand's a buy at this level? I think so
Technicals :
Price broke important level of resistance at $112 and had a nice run to $132. No we are in pullback, restesting previous resistance that now can act like support. And looks like we are curling up and can see new highs soon
Trade and Risk management:
We already have an initial entry, as price came out of consolidation above $121.40. I will initiate small position here with stop below $114.50 and will see if it can build new construction in front of high at $131.85 ot add to my position.